238 related articles for article (PubMed ID: 23190601)
61. Napsin A is frequently expressed in clear cell carcinoma of the ovary and endometrium.
Iwamoto M; Nakatani Y; Fugo K; Kishimoto T; Kiyokawa T
Hum Pathol; 2015 Jul; 46(7):957-62. PubMed ID: 25971546
[TBL] [Abstract][Full Text] [Related]
62. Immunohistochemical Detection of Pax8 and Napsin A in Canine Thyroid Tumours: Comparison with Thyroglobulin, Calcitonin and Thyroid Transcription Factor 1.
Ramos-Vara JA; Frank CB; DuSold D; Miller MA
J Comp Pathol; 2016 Nov; 155(4):286-298. PubMed ID: 27567273
[TBL] [Abstract][Full Text] [Related]
63. Role of Napsin A and Survivin Immunohistochemical Expression in Bronchogenic Adenocarcinoma.
Mohammed Salama ME
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3345-3348. PubMed ID: 33247694
[TBL] [Abstract][Full Text] [Related]
64. High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features.
Sun PL; Seol H; Lee HJ; Yoo SB; Kim H; Xu X; Jheon S; Lee CT; Lee JS; Chung JH
J Thorac Oncol; 2012 Feb; 7(2):323-30. PubMed ID: 22237264
[TBL] [Abstract][Full Text] [Related]
65. Utility of thyroid transcription factor-1 expression in the differential diagnosis of metastatic adenocarcinoma of serous effusion specimens prepared using the cell transfer technique.
Jan IS; Chung PF; Weng MH; Huang MS; Lee YT; Kuo SH
J Formos Med Assoc; 2006 Sep; 105(9):695-700. PubMed ID: 16959616
[TBL] [Abstract][Full Text] [Related]
66. Unusual expression of thyroid transcription factor 1 and napsin A in metastatic adenoid cystic carcinoma of extrapulmonary origin in the lung.
An J; Park S; Sung SH; Cho MS; Kim SC
Am J Clin Pathol; 2014 May; 141(5):712-7. PubMed ID: 24713744
[TBL] [Abstract][Full Text] [Related]
67. Thyroid transcription factor-1 expression is an independent predictor of recurrence and correlates with the IASLC/ATS/ERS histologic classification in patients with stage I lung adenocarcinoma.
Kadota K; Nitadori J; Sarkaria IS; Sima CS; Jia X; Yoshizawa A; Rusch VW; Travis WD; Adusumilli PS
Cancer; 2013 Mar; 119(5):931-8. PubMed ID: 23096929
[TBL] [Abstract][Full Text] [Related]
68. IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype.
Walter O; Prasad M; Lu S; Quinlan RM; Edmiston KL; Khan A
Hum Pathol; 2009 Nov; 40(11):1528-33. PubMed ID: 19695680
[TBL] [Abstract][Full Text] [Related]
69. Expression of CC chemokine receptor 9 predicts poor prognosis in patients with lung adenocarcinoma.
Zhong Y; Jiang L; Lin H; Li B; Lan J; Liang S; Shen B; Lei Z; Zheng W
Diagn Pathol; 2015 Jul; 10():101. PubMed ID: 26168791
[TBL] [Abstract][Full Text] [Related]
70. Expression of caveolin-1 is correlated with disease stage and survival in lung adenocarcinomas.
Zhan P; Shen XK; Qian Q; Wang Q; Zhu JP; Zhang Y; Xie HY; Xu CH; Hao KK; Hu W; Xia N; Lu GJ; Yu LK
Oncol Rep; 2012 Apr; 27(4):1072-8. PubMed ID: 22200856
[TBL] [Abstract][Full Text] [Related]
71. Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study.
Jiang Z; Chu PG; Woda BA; Rock KL; Liu Q; Hsieh CC; Li C; Chen W; Duan HO; McDougal S; Wu CL
Lancet Oncol; 2006 Jul; 7(7):556-64. PubMed ID: 16814207
[TBL] [Abstract][Full Text] [Related]
72. [Thyroid transcription factor-1 in pulmonary cytology].
Smojver-Jezek S; Vrabec-Branica B; Juros Z; Boras Z; Cucević B; Mazuranić I
Acta Med Croatica; 2008 Oct; 62(4):373-8. PubMed ID: 19205414
[TBL] [Abstract][Full Text] [Related]
73. The expression of IMP3 in 366 cases with ovarian carcinoma of high grade serous, endometrioid and clear cell subtypes.
Lu L; Wang S; Zhu Q; Qu Y; Gu W; Ning Y; Chen X; Wang Y
Pathol Res Pract; 2018 Aug; 214(8):1087-1094. PubMed ID: 29866423
[TBL] [Abstract][Full Text] [Related]
74. Comparison of the dysadherin and E-cadherin expression in primary lung cancer and metastatic sites.
Mitselou A; Batistatou A; Nakanishi Y; Hirohashi S; Vougiouklakis T; Charalabopoulos K
Histol Histopathol; 2010 Oct; 25(10):1257-67. PubMed ID: 20712010
[TBL] [Abstract][Full Text] [Related]
75. Insulin-like growth factor II-messenger RNA-binding protein-3 and lung cancer.
Findeis-Hosey JJ; Xu H
Biotech Histochem; 2012 Jan; 87(1):24-9. PubMed ID: 21838610
[TBL] [Abstract][Full Text] [Related]
76. Napsin-A, TTF-1, EGFR, and ALK Status Determination in Lung Primary and Metastatic Mucin-Producing Adenocarcinomas.
Rossi G; Cavazza A; Righi L; Sartori G; Bisagni A; Longo L; Pelosi G; Papotti M
Int J Surg Pathol; 2014 Aug; 22(5):401-7. PubMed ID: 24651909
[TBL] [Abstract][Full Text] [Related]
77. The application and diagnostic utility of immunocytochemistry on direct smears in the diagnosis of pulmonary adenocarcinoma and squamous cell carcinoma.
Roh MH; Schmidt L; Placido J; Farmen S; Fields KL; Courey AJ; Arenberg DA; Knoepp SM
Diagn Cytopathol; 2012 Nov; 40(11):949-55. PubMed ID: 21500373
[TBL] [Abstract][Full Text] [Related]
78. Napsin A levels in epithelial lining fluid as a diagnostic biomarker of primary lung adenocarcinoma.
Uchida A; Samukawa T; Kumamoto T; Ohshige M; Hatanaka K; Nakamura Y; Mizuno K; Higashimoto I; Sato M; Inoue H
BMC Pulm Med; 2017 Dec; 17(1):195. PubMed ID: 29233112
[TBL] [Abstract][Full Text] [Related]
79. IMP3 expression in biopsy specimens of colorectal cancer predicts lymph node metastasis and TNM stage.
Wei Q; Huang X; Fu B; Liu J; Zhong L; Yang Q; Zhao T
Int J Clin Exp Pathol; 2015; 8(9):11024-32. PubMed ID: 26617820
[TBL] [Abstract][Full Text] [Related]
80. A resectable pancreatic metastasis from pulmonary adenocarcinoma.
Igai H; Kamiyoshihara M; Nagashima T; Ohtaki Y; Shimizu K
Ann Thorac Cardiovasc Surg; 2014; 20(3):243-5. PubMed ID: 23364227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
